Pfizer has only announced it's study of vaccinating under 12s at a press conference and it is still not even out as a pre print article in journals.More importantly the evidence hasn't been presented to the FDA.Note that the FDA spokesman said hopefully a decision would be made in several weeks once the application is made.So unlikely to be a decision before December.That means unlikely to be approved in Australia until 2022.
Also note that the Pfizer study is with children 5 - 11 whereas Moderna is studying vaccinating those from 6 months and over.
Another report of the Pfizer press conference.
Pfizer on Monday announced that testing showed that its COVID-19 vaccine was “safe” and “well tolerated” by children ages 5 to 11, and “robust neutralizing a…
thehill.com
I have a sneaking impression that the FDA does not like Pfizer's use of press releases.They have just voted on the use of boosters by Pfizer.The vote was 16 -2 against general use of a booster dose at 6 months.
By Denise BaezThe US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee voted against giving a third dose, or a booster dose, of Pfizer’s coronavirus disease 2019 (COVID-19) mRNA vaccine (BNT162b2) in individuals aged 16 years and older.Of the 18...
dgalerts.docguide.com
That means the Pfizer booster has not been authorised for the majority of those over 16.